Johnson & Johnson Logo

Johnson & Johnson (JNJ)

SIX

Currency in CHF
218.25
0.00 (0.00%)

Real-time Data

07:00 AM

Day's Range

218.25
218.25

52 wk Range

172.65
219.95

Overview - JNJ - Johnson & Johnson

Key Statistics

Valuation

Enterprise Value

442.85B

P/E (Trailing)

‪30.18‬

PEG Ratio

‪-264.05‬

Price / Sales (TTM)

‪5.18‬

Price / Book

‪7.35‬

EV / EBITDA

‪15.89‬

Profitability

Gross Margin

‪68.19%‬

Profit Margin

‪21.48%‬

Operating Margin

‪29.19%‬

Return on Assets

‪8.59%‬

Return on Equity

‪25.74%‬

Ownership

Shares Outstanding

2.40B

Float

2.40B

Held by Insiders

‪0.05%‬

Held by Institutions

‪76.91%‬

Price stats

Beta

‪0.23‬

50-Day Avg

‪205.69‬

200-Day Avg

‪191.31‬

Dividends

Payout Ratio

‪30.62%‬

Frequency

Quarterly

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - JNJ - Johnson & Johnson

Peers - JNJ - Johnson & Johnson

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on SIX.

Profile Summary - JNJ - Johnson & Johnson

About

Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience,…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees138.20K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.